These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 15774815)
1. Trends in survival of patients with metastatic breast cancer. Voogd AC; van Gestel K; Ernst MF J Clin Oncol; 2005 Mar; 23(9):2116; author reply 2116-7. PubMed ID: 15774815 [No Abstract] [Full Text] [Related]
2. Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002. Ernst MF; van de Poll-Franse LV; Roukema JA; Coebergh JW; van Gestel CM; Vreugdenhil G; Louwman MJ; Voogd AC Breast; 2007 Aug; 16(4):344-51. PubMed ID: 17303426 [TBL] [Abstract][Full Text] [Related]
3. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Ruiterkamp J; Ernst MF; van de Poll-Franse LV; Bosscha K; Tjan-Heijnen VC; Voogd AC Eur J Surg Oncol; 2009 Nov; 35(11):1146-51. PubMed ID: 19398188 [TBL] [Abstract][Full Text] [Related]
4. Shortened survival and more metastasis recurrences among overweight breast cancer patients. Majed B; Senouci K; Asselain B Breast J; 2009; 15(5):557-9. PubMed ID: 19671109 [No Abstract] [Full Text] [Related]
5. Survival impact of integrative cancer care in advanced metastatic breast cancer. Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J Breast J; 2009; 15(4):357-66. PubMed ID: 19470134 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cancer registry and clinical data as predictors for breast cancer survival. Seppänen J; Heinävaara S; Holli K; Hakulinen T Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035 [TBL] [Abstract][Full Text] [Related]
7. Endocrine therapy in metastatic breast cancer: data from Breast Cancer Registry of Palermo, 1999-2005 . Amodio R; Zarcone M; Agostara B; Staiti R; Granata OM; Carruba G; Traina A Ann N Y Acad Sci; 2009 Feb; 1155():227-31. PubMed ID: 19250208 [TBL] [Abstract][Full Text] [Related]
8. A novel approach to T classification in tumor-node-metastasis staging of breast cancer. Coburn NG; Clarke-Pearson E; Chung MA; Law C; Fulton J; Cady B Am J Surg; 2006 Oct; 192(4):434-8. PubMed ID: 16978944 [TBL] [Abstract][Full Text] [Related]
9. Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival. Zhang X; Shu XO; Cai Q; Ruan Z; Gao YT; Zheng W Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6037-42. PubMed ID: 17062678 [TBL] [Abstract][Full Text] [Related]
10. The influence of basal phenotype on the metastatic pattern of breast cancer. Luck AA; Evans AJ; Green AR; Rakha EA; Paish C; Ellis IO Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):40-5. PubMed ID: 17981444 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer survival. The Ohio state university hospitals. Minton JP; Sabback MS; Oberle KV Ohio State Med J; 1972 Dec; 68(12):1099. PubMed ID: 4641049 [No Abstract] [Full Text] [Related]
12. Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. Paci E; Ponti A; Crocetti E; Zappa M; Segnan N J Natl Cancer Inst; 2005 Dec; 97(24):1853-4; author reply 1854. PubMed ID: 16368949 [No Abstract] [Full Text] [Related]
13. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors. Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319 [TBL] [Abstract][Full Text] [Related]
14. Letter to the editor. Women with HER2-positive metastatic breast cancer have significantly longer survival after diagnosis of brain metastasis(BM) than those with HER2-negative disease. Kilickap S; Arslan C Am J Clin Oncol; 2009 Apr; 32(2):226. PubMed ID: 19346820 [No Abstract] [Full Text] [Related]
15. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Fields RC; Jeffe DB; Trinkaus K; Zhang Q; Arthur C; Aft R; Dietz JR; Eberlein TJ; Gillanders WE; Margenthaler JA Ann Surg Oncol; 2007 Dec; 14(12):3345-51. PubMed ID: 17687611 [TBL] [Abstract][Full Text] [Related]
16. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit. Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S Breast J; 2006; 12(6):531-5. PubMed ID: 17238982 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of long-term (5-year) survival in patients with metastatic breast cancer to the liver]. Kan N Gan To Kagaku Ryoho; 2006 Nov; 33(12):1780-4. PubMed ID: 17212106 [TBL] [Abstract][Full Text] [Related]
18. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. Chew HK; Wun T; Harvey DJ; Zhou H; White RH J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906 [TBL] [Abstract][Full Text] [Related]
19. Clinical management of women with metastatic breast cancer: a descriptive study according to age group. Manders K; van de Poll-Franse LV; Creemers GJ; Vreugdenhil G; van der Sangen MJ; Nieuwenhuijzen GA; Roumen RM; Voogd AC BMC Cancer; 2006 Jul; 6():179. PubMed ID: 16824210 [TBL] [Abstract][Full Text] [Related]
20. [Minimal residual disease in breast cancer: detection and clinical relevance]. Pantel K; Wölfle U Verh Dtsch Ges Pathol; 2005; 89():68-75. PubMed ID: 18035675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]